GE HealthCare Technologies Inc. (GEHC)

78.26 +2.02 (+2.65%) 收市：04:00PM EDT

GE HealthCare Technologies Inc.

500 West Monroe Street
Chicago, IL 60661
United States
833 735 1139
https://www.gehealthcare.com

版塊: Healthcare
行業: Health Information Services
全職員工: 51,000

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Peter J. Arduini	President, CEO & Director	4.29M	無	1965
Mr. James K. Saccaro	VP & CFO	1.52M	無	1973
Dr. Taha Kass-Hout M.D., M.S.	Chief Science & Technology Officer	4.61M	無	1972
Mr. Frank R. Jimenez Esq.	VP, General Counsel & Corporate Secretary	2.06M	無	1965
Mr. Jan Makela	President & CEO of Imaging	1.57M	2.27M	1969
Mr. George Andrew Newcomb	Controller & Chief Accounting Officer	無	無	1967
Mr. Jahid Khandaker	Chief Information Officer	無	無	無
Ms. Carolynne Borders	Chief Investor Relations Officer	無	無	無
Ms. Rana Strellis	Chief Corporate Marketing & Communications Officer	無	無	無
Mr. Thomas J. Westrick	President & CEO of Patient Care Solutions	無	無	1969

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

公司管治

截至 2024年4月29日 止，GE HealthCare Technologies Inc. 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中：7；董事會：6；股東權利：5；現金賠償：4。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。